Abstract: The present invention relates to a method for increasing the embryo implantation rate in a mammalian uterus, by administering to the uterus of a mammal an effective amount of an extracellular matrix remodeling enzyme, as well as to a product which includes an extracellular remodeling enzyme.
Type:
Grant
Filed:
October 9, 2023
Date of Patent:
July 1, 2025
Assignee:
NanoCell Ltd.
Inventors:
Irit Sagi, Inna Solomonov, Eldar Zehorai
Abstract: The present invention relates to a method for increasing the embryo implantation rate in a mammalian uterus, by administering to the uterus of a mammal an effective amount of an extracellular matrix remodeling enzyme, as well as to a product comprising an extracellular remodeling enzyme.
Type:
Application
Filed:
October 9, 2023
Publication date:
February 8, 2024
Applicant:
NanoCell Ltd.
Inventors:
Irit SAGI, Inna SOLOMONOV, Eldar ZEHORAI
Abstract: The present invention relates to a method for increasing the embryo implantation rate in a mammalian uterus, by administering to the uterus of a mammal an effective amount of an extracellular matrix remodeling enzyme, as well as to a product comprising an extracellular remodeling enzyme.
Type:
Grant
Filed:
July 7, 2022
Date of Patent:
October 10, 2023
Assignee:
NanoCell Ltd.
Inventors:
Irit Sagi, Inna Solomonov, Eldar Zehorai
Abstract: The present invention relates to a method for increasing the embryo implantation rate in a mammalian uterus, by administering to the uterus of a mammal an effective amount of an extracellular matrix remodeling enzyme, as well as to a product comprising an extracellular remodeling enzyme.
Type:
Application
Filed:
July 7, 2022
Publication date:
November 3, 2022
Applicant:
NanoCell Ltd.
Inventors:
Irit SAGI, Inna SOLOMONOV, Eldar ZEHORAI
Abstract: The present invention relates to a method for increasing the embryo implantation rate in a mammalian uterus, by administering to the uterus of a mammal an effective amount of an extracellular matrix remodeling enzyme, as well as to a product comprising an extracellular remodeling enzyme.
Type:
Grant
Filed:
June 17, 2020
Date of Patent:
July 12, 2022
Assignee:
NanoCell Ltd.
Inventors:
Irit Sagi, Inna Solomonov, Eldar Zehorai
Abstract: The present invention relates to a method for increasing the embryo implantation rate in a mammalian uterus, by administering to the uterus of a mammal an effective amount of an extracellular matrix remodeling enzyme, as well as to a product comprising an extracellular remodeling enzyme.
Type:
Application
Filed:
June 17, 2020
Publication date:
January 21, 2021
Applicant:
NanoCell Ltd.
Inventors:
Irit SAGI, Inna SOLOMONOV, Eldar ZEHORAI
Abstract: The present invention relates to a method for increasing the embryo implantation rate in a mammalian uterus, by administering to the uterus of a mammal an effective amount of an extracellular matrix remodeling enzyme, as well as to a product comprising an extracellular remodeling enzyme.
Type:
Grant
Filed:
April 1, 2016
Date of Patent:
July 28, 2020
Assignee:
NanoCell Ltd.
Inventors:
Irit Sagi, Inna Solomonov, Eldar Zehorai